Proteomics and metabonomics analyses of Covid-19 complications in patients with pulmonary fibrosis

Abstract Pulmonary fibrosis is a devastating disease, and the pathogenesis of this disease is not completely clear. Here, the medical records of 85 Covid-19 cases were collected, among which fibrosis and progression of fibrosis were analyzed in detail. Next, data independent acquisition (DIA) quanti...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jianrong Yang, Chunxia Chen, Wan Chen, Luying Huang, Zhao Fu, Kun Ye, Liwen Lv, Zhihuang Nong, Xing Zhou, Wensheng Lu, Mei Zhong
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/5612f91bb5fa49babedc218abf921df8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5612f91bb5fa49babedc218abf921df8
record_format dspace
spelling oai:doaj.org-article:5612f91bb5fa49babedc218abf921df82021-12-02T16:14:09ZProteomics and metabonomics analyses of Covid-19 complications in patients with pulmonary fibrosis10.1038/s41598-021-94256-82045-2322https://doaj.org/article/5612f91bb5fa49babedc218abf921df82021-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-94256-8https://doaj.org/toc/2045-2322Abstract Pulmonary fibrosis is a devastating disease, and the pathogenesis of this disease is not completely clear. Here, the medical records of 85 Covid-19 cases were collected, among which fibrosis and progression of fibrosis were analyzed in detail. Next, data independent acquisition (DIA) quantification proteomics and untargeted metabolomics were used to screen disease-related signaling pathways through clustering and enrichment analysis of the differential expression of proteins and metabolites. The main imaging features were lesions located in the bilateral lower lobes and involvement in five lobes. The closed association pathways were FcγR-mediated phagocytosis, PPAR signaling, TRP-inflammatory pathways, and the urea cycle. Our results provide evidence for the detection of serum biomarkers and targeted therapy in patients with Covid-19.Jianrong YangChunxia ChenWan ChenLuying HuangZhao FuKun YeLiwen LvZhihuang NongXing ZhouWensheng LuMei ZhongNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Jianrong Yang
Chunxia Chen
Wan Chen
Luying Huang
Zhao Fu
Kun Ye
Liwen Lv
Zhihuang Nong
Xing Zhou
Wensheng Lu
Mei Zhong
Proteomics and metabonomics analyses of Covid-19 complications in patients with pulmonary fibrosis
description Abstract Pulmonary fibrosis is a devastating disease, and the pathogenesis of this disease is not completely clear. Here, the medical records of 85 Covid-19 cases were collected, among which fibrosis and progression of fibrosis were analyzed in detail. Next, data independent acquisition (DIA) quantification proteomics and untargeted metabolomics were used to screen disease-related signaling pathways through clustering and enrichment analysis of the differential expression of proteins and metabolites. The main imaging features were lesions located in the bilateral lower lobes and involvement in five lobes. The closed association pathways were FcγR-mediated phagocytosis, PPAR signaling, TRP-inflammatory pathways, and the urea cycle. Our results provide evidence for the detection of serum biomarkers and targeted therapy in patients with Covid-19.
format article
author Jianrong Yang
Chunxia Chen
Wan Chen
Luying Huang
Zhao Fu
Kun Ye
Liwen Lv
Zhihuang Nong
Xing Zhou
Wensheng Lu
Mei Zhong
author_facet Jianrong Yang
Chunxia Chen
Wan Chen
Luying Huang
Zhao Fu
Kun Ye
Liwen Lv
Zhihuang Nong
Xing Zhou
Wensheng Lu
Mei Zhong
author_sort Jianrong Yang
title Proteomics and metabonomics analyses of Covid-19 complications in patients with pulmonary fibrosis
title_short Proteomics and metabonomics analyses of Covid-19 complications in patients with pulmonary fibrosis
title_full Proteomics and metabonomics analyses of Covid-19 complications in patients with pulmonary fibrosis
title_fullStr Proteomics and metabonomics analyses of Covid-19 complications in patients with pulmonary fibrosis
title_full_unstemmed Proteomics and metabonomics analyses of Covid-19 complications in patients with pulmonary fibrosis
title_sort proteomics and metabonomics analyses of covid-19 complications in patients with pulmonary fibrosis
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/5612f91bb5fa49babedc218abf921df8
work_keys_str_mv AT jianrongyang proteomicsandmetabonomicsanalysesofcovid19complicationsinpatientswithpulmonaryfibrosis
AT chunxiachen proteomicsandmetabonomicsanalysesofcovid19complicationsinpatientswithpulmonaryfibrosis
AT wanchen proteomicsandmetabonomicsanalysesofcovid19complicationsinpatientswithpulmonaryfibrosis
AT luyinghuang proteomicsandmetabonomicsanalysesofcovid19complicationsinpatientswithpulmonaryfibrosis
AT zhaofu proteomicsandmetabonomicsanalysesofcovid19complicationsinpatientswithpulmonaryfibrosis
AT kunye proteomicsandmetabonomicsanalysesofcovid19complicationsinpatientswithpulmonaryfibrosis
AT liwenlv proteomicsandmetabonomicsanalysesofcovid19complicationsinpatientswithpulmonaryfibrosis
AT zhihuangnong proteomicsandmetabonomicsanalysesofcovid19complicationsinpatientswithpulmonaryfibrosis
AT xingzhou proteomicsandmetabonomicsanalysesofcovid19complicationsinpatientswithpulmonaryfibrosis
AT wenshenglu proteomicsandmetabonomicsanalysesofcovid19complicationsinpatientswithpulmonaryfibrosis
AT meizhong proteomicsandmetabonomicsanalysesofcovid19complicationsinpatientswithpulmonaryfibrosis
_version_ 1718384350050910208